TRVI (STOCKS)
Trevi Therapeutics, Inc. Common Stock
$12.110000
+0.050000 (+0.41%)
Prev close: $12.060000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jennifer L. Good
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,724.67M
- Employees
- 33
- P/E (TTM)
- -35.19
- P/B (TTM)
- 5.34
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
11
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.11 | $-0.11 | +0.0025 | +2.22% |
|
Mar 2026 (Q1)
|
$-0.09 | $-0.08 | -0.0120 | -15.38% |
|
Dec 2025 (Q4)
|
$-0.06 | $-0.10 | +0.0401 | +40.06% |
|
Sep 2025 (Q3)
|
$-0.08 | $-0.10 | +0.0203 | +20.24% |